Patients with concomitant p53 mutations had significantly less ORR and showed a trend for a shorter mPFS; among the 8 patients with sarcomatoid histologies harbouring POT-1 mutations, they showed a non-significant lower ORR and shorter mPFS with respect to patients with POT-1 wild type [ 94 ].
← all excerpts
MET in Non-Small-Cell Lung Cancer (NSCLC): Cross 'a Long and Winding Road' Looking for a Target.
1
—
—